Integrated Safety Analysis of Telotristat Ethyl in Patients With Carcinoid Heart Disease

Lapuerta P, Kulke MH, Pavel ME, Biran T, Fleming R, Zacks JS, Hoffmanns P, Warner RRP (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Pancreas Lippincott, Williams & Wilkins

Book Volume: 47

Pages Range: 345-345

Journal Issue: 3

Authors with CRIS profile

Marianne Ellen Pavel Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Involved external institutions

Icahn School of Medicine at Mount Sinai

United States (USA) (US) Lexicon Pharmaceuticals, Inc.

United States (USA) (US) Ipsen Pharma GmbH

Germany (DE) Dana–Farber Cancer Institute

United States (USA) (US)

How to cite

APA:

Lapuerta, P., Kulke, M.H., Pavel, M.E., Biran, T., Fleming, R., Zacks, J.S.,... Warner, R.R.P. (2018). Integrated Safety Analysis of Telotristat Ethyl in Patients With Carcinoid Heart Disease. (pp. 345-345).

MLA:

Lapuerta, Pablo, et al. "Integrated Safety Analysis of Telotristat Ethyl in Patients With Carcinoid Heart Disease." 2018. 345-345.

BibTeX: Download